Yissum Spinouts Raise $79 million in H1 2020 Despite Coronavirus Uncertainty - PRNewswire

...opment company, and Nectin Therapeutics, an immune-oncology biotech focused on cancer therapies.
About Yissum
Yissum is the technology transfer company of the Hebrew University of Jerusalem. Founded in 1964, it serves as...
Read Full Article